Additionally, the tumor microenvironment (TME) is enriched with inhibitory cytokines like TGF-β, which collectively create a hostile environment that dampens cytotoxic T-cell activity and impairs the overall immune response against the tumor [3, 23, 24]. This evidence concerns the gene TGFB1 and neoplasm.